Physician profile
Mohammed Ali
NPI 1295113702
$874.06
in general payments reported to CMS, 2019-2025
12 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $23.68 · 2021: $58.29 · 2023: $222 · 2024: $14.09 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489 · Education: $50.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.38 |
| Education | $50.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $209.06 | 2019 | |
| Abbott Laboratories | $147.39 | 2025 | Eterna |
| Genzyme Corporation | $135.45 | 2023 | |
| Ethicon INC. | $95.05 | 2025 | Monarch Platform |
| Stryker Corporation | $61.62 | 2025 | Flowtriever |
| La Jolla Pharmaceutical Company | $58.29 | 2021 | |
| Chiesi USA, INC. | $50.40 | 2023 | Cleviprex |
| Abiomed | $35.78 | 2023 | Impella |
| Ekos Corporation | $27.63 | 2019 | |
| Insmed, INC. | $23.68 | 2020 | |
| Merck Sharp & Dohme LLC | $15.62 | 2019 | |
| Intuitive Surgical, INC. | $14.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.